Article
Arsenic trioxide resistance in acute promyelocytic leukemia: More to it than PML mutations
medRxiv · 2020 · Balasundaram, N.; Ganesan, S.; Chendamarai, E.; Palani, H. K.; Venkatraman, A.; Alex, A. A.; David, S.; Krishna, S.; Korula, A.; Janet, N. B.; Balasubramanian, P.; Mathews, V.
Key facts
| Title | Arsenic trioxide resistance in acute promyelocytic leukemia: More to it than PML mutations |
|---|---|
| First author | Balasundaram, N.; Ganesan, S.; Chendamarai, E.; Palani, H. K.; Venkatraman, A.; Alex, A. A.; David, S.; Krishna, S.; Korula, A.; Janet, N. B.; Balasubramanian, P.; Mathews, V. |
| Journal | medRxiv |
| Published | Jun 21, 2020 |
| DOI | 10.1101/2020.06.21.154633 |
| Devices mentioned | BK110039, K040782, K103302, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840 and 13 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JAK, KKX, NDS and 5 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1